Zobrazeno 1 - 5
of 5
pro vyhledávání: '"ALEXANDER H. SPARRE-ULRICH"'
Autor:
Mette H. Jensen, Samra J. Sanni, Ditte Riber, Jens J. Holst, Mette M. Rosenkilde, Alexander H. Sparre-Ulrich
Publikováno v:
Molecular Metabolism, Vol 88, Iss , Pp 102006- (2024)
Objectives: Obesity represents a global health crisis with significant patient burdens and healthcare costs. Despite the advances with glucagon-like peptide-1 (GLP-1) receptor agonists in treating obesity, unmet needs remain. This study characterizes
Externí odkaz:
https://doaj.org/article/25f7b2dd9c3443ce984912d0de8ad0d3
Autor:
Albert Zlotnik, Osamu Yoshie, Mohib Uddin, Marcus Thelen, Alexander H. Sparre-Ulrich, Silvano Sozzani, Antal Rot, Mette M. Rosenkilde, Amanda E. I. Proudfoot, Christine A. Power, Joost J. Oppenheim, Hisayuki Nomiyama, Robert J. B. Nibbs, Philip M. Murphy, Georgios L. Moschovakis, Amy E. Monaghan, Kouji Matsushima, Alberto Mantovani, Andrew D. Luster, Massimo Locati, Richard Horuk, Rebecca Hills, Gerard J. Graham, Joshua M. Farber, Reinhold Förster, Christophe Combadiere, Israel F. Charo, Amanda M. Burkhardt, Adit Ben-Baruch, Francoise Bachelerie
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2023
Chemokine receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Chemokine Receptors [438, 437, 32]) comprise a large subfamily of 7TM proteins that bind one or more chemokines, a large family of small cytokines typically possessing chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdabff92dd3a87ec119470747102cddc
https://doi.org/10.2218/gtopdb/f14/2023.1
https://doi.org/10.2218/gtopdb/f14/2023.1
Autor:
Signe Stensen, Liva L. Krogh, Alexander H. Sparre‐Ulrich, Flemming Dela, Bolette Hartmann, Tina Vilsbøll, Jens J. Holst, Mette M. Rosenkilde, Mikkel B. Christensen, Lærke S. Gasbjerg, Filip K. Knop
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1882-1887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72117d1cb63dd140d1255e1806c2ded2
https://doi.org/10.1111/dom.14736
https://doi.org/10.1111/dom.14736
Autor:
LÆRKE S. GASBJERG, MADS M. HELSTED, SIGNE STENSEN, LIVA S.L. KROGH, ALEXANDER H. SPARRE-ULRICH, BOLETTE HARTMANN, TINA VILSBØLL, MIKKEL B. CHRISTENSEN, JENS J. HOLST, CHRISTINA CHRISTOFFERSEN, FILIP K. KNOP, METTE M. ROSENKILDE
Publikováno v:
Diabetes. 71
The gut hormone glucose-dependent insulinotropic polypeptide (GIP) stimulates glucose-induced insulin secretion and increases triglyceride deposition in subcutaneous adipose tissue, and these effects are attenuated in both type 2 diabetes (T2D) and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eefff882db827dff4028ed840820d89d
https://doi.org/10.2337/db22-1362-p
https://doi.org/10.2337/db22-1362-p
Autor:
Lærke S, Gasbjerg, Mikkel B, Christensen, Bolette, Hartmann, Amalie R, Lanng, Alexander H, Sparre-Ulrich, Maria B N, Gabe, Flemming, Dela, Tina, Vilsbøll, Jens J, Holst, Mette M, Rosenkilde, Filip K, Knop
Publikováno v:
Diabetologia. 61(2)
Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone secreted postprandially from enteroendocrine K cells, but despite therapeutically interesting effects, GIP physiology in humans remains incompletely understood. Progress in thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c62028da121d1c7db916ea6431c33f8
https://pubmed.ncbi.nlm.nih.gov/28948296
https://pubmed.ncbi.nlm.nih.gov/28948296